The life of a product from manufacturer to patient!
HSE Dr Steevens, 4th May 2018
The HSE hosted the GS1 Ireland Healthcare User Group (HUG) Supplier Briefing on Friday 4th May 2018 in the Boardroom of HSE, Dr Steevens. The event was very well attended with nearly 100 delegates representing medical device suppliers and manufacturers as well as healthcare providers. The event focussed on the life of a medical device product as it travels from manufacturer to the patient.
Speakers: HUG Supplier Briefing Day May 2018
From L to R: Mike Byrne GS1, Declan O’Reilly GS Medical, Shay Farrelly Haemophilia Patient, John Swords HSE, Ronnie McDermott HSE, Maria Svejdar GS1, Siobhain Duggan GS1, Pat Tracey DCC Vital.
Shay Farrelly, a Haemophilia patient, spoke about the challenge faced by haemophilia patients to regain trust in the supply of medication after the hepatitis and HIV contamination scandal. Today, patients have a world-class track and trace solution that identifies, manages and records their medication. A key feature of the solution is a phone app that enables them to scan and record their medication at the point of care. Not only does this check and validate the treatment, but additionally informs their clinical care record, which leads to benefits for patient safety, efficiency and better quality care.
Presentation (PDF): Shay Farrelly, The Patient's Perspective
The theme of traceability was referenced throughout the morning. The second speaker John Swords, Head of Procurement HBS, HSE, confirmed the importance of unique identification to enable the implementation of the Electronic Health Record as well as the IFMS (Integrated Financial Management System) which is currently a major part of the HSE work programme.
“Track and trace is where we want to be going as part of the IFMS and EHR rollout. This is key for patient safety,” says John Swords, who confirmed that the GS1 Unique Identifier is part of many current HSE programmes, including the Individual Health Identifier (IHI).
Presentation (PDF): John Swords, Digitisation of Healthcare
Presentation (PDF): John Swords, HBS HSE Procurement
Manufacturers selling medical devices in Europe will be required to register their device information in the EUDAMED database by 2020; and from 2021 devices will be required to have a UDI barcode on the product packaging. The labelling of devices will be a phased approach similar to the US FDA regulation, starting with Class III devices. The regulation will require manufacturers to include the UDI in the Field Safety Notices and recall notices being provided to the regulatory bodies in each country.
Ronnie McDermott, HSE Medical Equipment Management Lead confirmed the importance of the UDI for managing both medical equipment and medical devices during his presentation. “RFID tags with 2D Datamatrix Barcodes are being rolled out as the standard asset identifier for all medical equipment across the HSE, for improved and enhanced patient safety,” said McDermott.
Presentation (PDF): Ronnie McDermott, Asset Identification and Tracking
The role of the manufacturer and distributor is vital in delivering UDI compliant products to the market. Declan O’Reilly from GS Medical and Maria Svejdar from GS1 Ireland presented an overview of how to get started with UDI barcoding. “Traceability is key, not just for our internal processes but most importantly for track and trace of products to the patient,” said Declan O’Reilly, GS Medical.
Presentation (PDF): Declan O'Reilly GS Medical & Maria Svejdar, GS1 Ireland, Getting Started with UDI & GTIN Barcoding
The EU UDI regulation also includes a requirement for healthcare providers to capture and store the UDI in their systems, preferably electronically, starting with Class III devices.
“The best unique identifier is the barcode and we see this as the single most reliable piece of information,” said John Swords, who spoke about the work being done in the National Distribution Centre (NDC) to standardise information using the UDI/GTIN (Global Trade Item Number) as the unique identifier in the HSE systems. This will support compliance to contracts and traceability of product to the patient. Collaboration with suppliers is a key part of this work and the audience were invited to work with the HSE to support the standardisation of coding and data. The time to act is now.
Presentation (PDF): John Swords, GTIN and Product Data for the NDC
For more information, please contact: Mike Byrne, CEO or Siobhain Duggan, Director of Healthcare and Innovation, GS1 Ireland
Tel: 01 208 0660 Email: firstname.lastname@example.org